Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The Study Locations section was expanded to include multiple U.S. states (Arizona, Arkansas, California, Connecticut, Florida, Indiana, Kansas, Nebraska, Nevada, New Hampshire, New Jersey, New York, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Wisconsin) and a new revision tag (v3.3.3).
    Difference
    2%
    Check dated 2025-12-23T21:21:58.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.2, replacing the previous v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-25T11:12:54.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Removal of the site-wide government funding notice that warned information may not be up to date. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:00:29.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    No significant content changes detected; only minor formatting or display adjustments appear without altering core study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:10:51.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T05:41:31.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.1.0 and removes several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while v3.0.2 remains as the prior revision reference.
    Difference
    0.3%
    Check dated 2025-09-29T03:08:44.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.